Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma

由 Guo, Hong-Qiang, Huang, Guo-Liang, Guo, Cheng-Cheng, Pu, Xing-Xiang, Lin, Tong-Yu
出版 2010

EGFR inhibitors sensitize non–small cell lung cancer cells to TRAIL-induced apoptosis

由 Xu, Fei, Tian, Ying, Huang, Yan, Zhang, Ling-Ling, Guo, Zheng-Zheng, Huang, Jia-Jia, Lin, Tong-Yu
出版 2011

Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma

由 GUO, HONG-QIANG, LIU, LEI, WANG, XIN-FENG, LIN, TONG-YU, YAO, SHU-NA, YAO, ZHI-HUA, YANG, SHU-JUN
出版 2014

Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphom...

由 Wang, Jing-hua, Wang, Liang, Liu, Cheng-cheng, Xia, Zhong-jun, Huang, Hui-qiang, Lin, Tong-yu, Jiang, Wen-qi, Lu, Yue
發表在 Oncotarget (2016)

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution

由 Huang, Jia-Jia, Xia, Yi, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
發表在 Oncotarget (2016)

Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen

由 Chen, Xing-Gui, Huang, He, Tian, Ying, Guo, Cheng-Cheng, Liang, Chao-Yong, Gong, Yao-Ling, Zou, Ben-Yan, Cai, Rui-Qing, Lin, Tong-Yu
出版 2011

Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes

由 Li, Ya-Jun, Jiang, Wen-Qi, Rao, Hui-Lan, Huang, Jia-Jia, Xia, Yi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun, Li, Su, Li, Zhi-Ming
出版 2012

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma

由 Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Wei, Wen-Xiao, Zhu, Ying-Jie, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi, Li, Zhi-Ming
出版 2013

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis

由 Song, Chen-Ge, Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Bi, Xi-Wen, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Li, Zhi-Ming
發表在 PLoS One (2015)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

由 Huang, JiaJia, Jiang, WenQi, Xu, RuiHua, Huang, HuiQiang, Lv, Yue, Xia, ZhongJun, Sun, XiaoFei, Guan, ZhongZhen, Lin, TongYu, Li, ZhiMing
出版 2010

High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma

由 Zhang, Xi, Huang, Jia-Jia, Xia, Yi, Li, Chao-Feng, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
發表在 Oncotarget (2016)

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

由 Hu, Li-Yang, Xu, Xiao-Lu, Rao, Hui-Lan, Chen, Jie, Lai, Ren-Chun, Huang, Hui-Qiang, Jiang, Wen-Qi, Lin, Tong-Yu, Xia, Zhong-Jun, Cai, Qing-Qing
發表在 Chin J Cancer (2017)

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

由 Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog
發表在 J Hematol Oncol (2020)

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

由 Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
發表在 Chin J Cancer (2016)

Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

由 Li, Ya-Jun, Li, Zhi-Ming, Xia, Yi, Huang, Jia-Jia, Huang, Hui-Qiang, Xia, Zhong-Jun, Lin, Tong-Yu, Li, Su, Cai, Xiu-Yu, Wu-Xiao, Zhi-Jun, Jiang, Wen-Qi
出版 2013

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

由 Tian, Xiao‐Peng, Cai, Jun, Ma, Shu‐Yun, Fang, Yu, Huang, Hui‐Qiang, Lin, Tong‐Yu, Rao, Hui‐Lan, Li, Mei, Xia, Zhong‐Jun, Kang, Tie‐Bang, Xie, Dan, Cai, Qing‐Qing
發表在 Cancer Commun (Lond) (2020)

Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

由 Li, Zhi-Ming, Huang, Jia-Jia, Xia, Yi, Sun, Jian, Huang, Ying, Wang, Yu, Zhu, Ying-Jie, Li, Ya-Jun, Zhao, Wei, Wei, Wen-Xiao, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi
出版 2012

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survi...

由 Chen, Kai-Lin, Chen, Jie, Rao, Hui-Lan, Guo, Ying, Huang, Hui-Qiang, Zhang, Liang, Shao, Jian-Yong, Lin, Tong-Yu, Jiang, Wen-Qi, Zou, De-Hui, Hu, Li-Yang, Wirian, Michael Lucas, Cai, Qing-Qing
發表在 Chin J Cancer (2015)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

由 Xu, Da-zhi, Geng, Qi-rong, Tian, Ying, Cai, Mu-yan, Fang, Xin-juan, Zhan, You-qing, Zhou, Zhi-wei, Li, Wei, Chen, Ying-bo, Sun, Xiao-wei, Guan, Yuan-xiang, Li , Yuan-fang, Lin, Tong-yu
出版 2010

Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2

由 Liu, Shu, Huang, He, Chen, Rong-xin, Wang, Zhao, Guan, Yan-ping, Peng, Chen, Fang, Xiao-jie, Chen, Zhuo-jia, Guan, Shao-xing, Zhu, Xia, Ren, Quan-guang, Yao, Yu-yi, Huang, Hong-bing, Huang, Min, Wang, Xue-ding, Lin, Tong-yu
發表在 Acta Pharmacol Sin (2020)